NOV 15, 2018 02:17 PM PST

Anti-inflammatory Drug Works Like an Inhibitor

WRITTEN BY: Nouran Amin

At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor.

Credit: The Scientist

The new anti-inflammatory drug molecule possess a unique mechanism of action. Essentially, the drug works by inhibiting a certain protein, called OGG1, which is studied to repair DNA was found to cause a reduction in the signals that trigger an inflammation.

The inhibitor works by blocking the release of inflammatory proteins, such as TNF alpha. During investigations on mice with acute pulmonary disease, the drug was found to dampen the inflammation.

Learn more about inflammatory responses:

In collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University--results of the findings are described in a publication in Science.

"We've developed a new drug molecule that inhibits inflammation," explains co-leader of the study, Professor Thomas Helleday, at the Department of Oncology-Pathology, Karolinska Institutet, Sweden. "It acts on a protein that we believe is a general mechanism for how inflammation arises in cells."

Discovery of the anti-inflammatory drug was the product of a long-term investigation on the mechanisms behind DNA repair—with the objective of fighting cancer by targeting a tumors cell’s DNA. Such research has resulted in several breakthrough drug discoveries including PARP inhibitors for the treatment of congenital breast and ovarian cancer.

Researchers were originally investigating the development of a new molecule that inhibits the enzyme, OGG1, which was found to be responsible for oxygen damage to DNA—that’s when they discovered that the molecule also dampened inflammation.

The result concluded that OGG1, apart from repairing DNA, triggers inflammation—making its inhibition critical in the treatment for inflammatory diseases.

"This discovery could give rise to a new treatment for a very serious condition," says Professor Helleday. "We'll now be developing our OGG1 inhibitor and examining whether it can lead to new treatments for inflammatory diseases in order to cure or relieve diseases such as sepsis, COPD and severe asthma."

Source: Science Magazine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Drug Delays Type 1 Diabetes in High Risk Individuals
An immunotherapeutic, involving anti-CD3 monoclonal antibody (teplizumab), was seen to slow down the progression to clinical type 1 diabetes in high risk i...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Drug Compound May Treat Common Genetic Kidney Disease
Researchers from the University of Sheffield in collaboration with Glasgow-based biotech company Mironid, have developed a new class of drugs for treating ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
'Sugar-coating' proteins to treat pancreatitis?
A powerful biomarker created by complex sugar molecules, called CA19-9, may be a target for the treatment of pancreatitis. Pancreatitis is an inflammatory ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Treating Drug-Resistant Acute Lymphoblastic Leukemia
New therapeutics may have helped improve survival rates for acute lymphoblastic leukemia patients but some patients still remain unresponsive to existing t...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Aspirin Usage Improves Liver Function After Embolization Treatment
Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving ...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
A Diabetic Drug that Promotes Brain Repair...But it Only Works in Females
Gender discrimination in research has long stopped serious advancements. In neuroscience, scientists believed that male brains are straightforward and do n...
Loading Comments...